Le mode conseil est activé Arrêter

Gilead Sciences, depositary receipt
BRGILDBDR000, GILD34

Ajouter une action à la Liste de suivi
Sélectionnez tout Réinitialiser tout
Gilead Sciences, pays — États-Unis
Aucunes données de trading
Représentation des données graphique | tableau
Source d'information - PJSC "MOEX". Toute autre diffusion des informations MOEX est interdite sans l'accord préalable de PJSC "MOEX".
Source d'information - PJSC "MOEX". Toute autre diffusion des informations MOEX est interdite sans l'accord préalable de PJSC "MOEX".
de
à
ADD-IN
Add-in Cbonds API
bond data api
Il faut s'enregistrer
Envoyer la demande d'accès accès
Plus de 2 500 éléments ont été trouvés, veuillez préciser votre demande
Pas de données sur la période choisie

Dernières cotations

explorer la base de données la plus complète

800 000

obligations globalement

Plus de 400

sources de prix

80 000

actions

9 000

ETF

suivre votre portefeuille de la manière la plus efficace
screener d'obligations
liste de surveillance
Excel ADD-IN
Obtenir l'accès

Émetteur

Profil
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases. The Company primary areas of focus include HIV, AIDS, liver disease, and ...
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases. The Company primary areas of focus include HIV, AIDS, liver disease, and serious cardiovascular and respiratory conditions.
Montrer tout Cacher
  • Emetteur
  • Nom complet de l'emprunteur / émetteur
    Gilead Sciences Inc
  • Secteur (industrie)
    Production de médicaments et biotechnologies

Rapports IFRS / US GAAP

2023
I q ang
II q ang
III q ang
IV q ang
2022
I q ang
II q ang
III q ang
IV q ang
2021
I q ang
II q ang
III q ang
IV q ang
2020
I q ang
II q ang
III q ang
IV q ang
2019
I q ang
II q ang
III q ang
IV q ang
2018
I q ang
II q ang
III q ang
IV q ang
2017
I q ang
II q ang
III q ang
IV q ang
2016
I q ang
II q ang
III q ang
IV q ang
2015
I q ang
II q ang
III q ang
IV q ang
2014
IV q ang
Afficher tout Masquer
Il faut s'enregistrer
Envoyer la demande d'accès accès

Indicateurs

Actualités

22/03/2024 Gilead Sciences: Regulation Fd Disclosure, Other Events, Financial Statements And Exhibits
11/02/2024 Gilead Sciences: Entry Into A Material Definitive Agreement, Other Events, Financial Statements And Exhibits
01/02/2024 Gilead Sciences: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Financial Statements And Exhibits
21/12/2023 S&P Global Ratings affirms Gilead Sciences at "BBB+" (Local Currency LT credit rating); outlook positive
21/12/2023 S&P Global Ratings affirms Gilead Sciences at "BBB+" (Foreign Currency LT credit rating); outlook positive
Toutes les actualités de l'organisation

Autres actions et certificats de dépôt

Obligations nationales et internationales de l'émetteur

Afficher tout

Détenteurs

Leaders de l'industrie

Vous devez vous inscrire pour y accéder.